23 May 2013
Keywords: shire, acquires, full, uk, ireland, rights, reminyl
Article | 12 April 2004
Shire Pharmaceuticals of the UK has acquired the exclusive rights to Reminyl (galantamine) in the UK and Ireland from Johnson & ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 April 2004
19 April 2004
22 May 2013
© 2013 thepharmaletter.com